Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients.
Vicini E, Galimberti V, Leonardi MC, Kahler-Ribeiro-Fontana S, Polizzi A, Petitto S, Pagan E, Bagnardi V, Montagna E, Cavallone M, Caldarella P, Intra M, Veronesi P. Vicini E, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2025 Jan 8. doi: 10.1007/s10549-024-07604-3. Online ahead of print. Breast Cancer Res Treat. 2025. PMID: 39776333
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Colleoni M, Bagnardi V, Rotmensz N, Gelber RD, Viale G, Pruneri G, Veronesi P, Torrisi R, Cardillo A, Montagna E, Campagnoli E, Luini A, Intra M, Galimberti V, Scarano E, Peruzzotti G, Goldhirsch A. Colleoni M, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2009 Jul;116(2):359-69. doi: 10.1007/s10549-008-0223-y. Epub 2008 Oct 22. Breast Cancer Res Treat. 2009. PMID: 18941889 Clinical Trial.
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, Monti S, Luini A, Raviele PR, Mastropasqua MG, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2011 Oct;129(3):867-75. doi: 10.1007/s10549-011-1697-6. Epub 2011 Aug 6. Breast Cancer Res Treat. 2011. PMID: 21822638 Clinical Trial.
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center.
Nicosia L, Lissidini G, Sargenti M, Bozzini AC, Farante G, Vila J, Oriecuia C, Pagan E, Bagnardi V, Lazzeroni M, Pesapane F, Sangalli C, Galimberti V, Cassano E, Veronesi P. Nicosia L, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2022 Nov;196(2):371-377. doi: 10.1007/s10549-022-06689-y. Epub 2022 Sep 17. Breast Cancer Res Treat. 2022. PMID: 36114939 Free PMC article.
Male breast cancer: a multicenter study to provide a guide for proper management.
Lissidini G, Nicosia L, Sargenti M, Cucchi MC, Fabi A, Falco G, Gardani M, Grilz G, Maugeri I, Murgo R, Neri A, Pellini F, Sensi C, Scomersi S, Taffurelli M, Bagnardi V, Oriecuia C, Pagan E, Sangalli C, Dessena M, Veronesi P, Galimberti V. Lissidini G, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2024 Nov;208(1):29-40. doi: 10.1007/s10549-024-07380-0. Epub 2024 Jun 19. Breast Cancer Res Treat. 2024. PMID: 38896332
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Pruneri G, Veronesi P, Cancello G, Balduzzi A, Dellapasqua S, Cardillo A, Luini A, Zurrida S, Gentilini O, Mastropasqua MG, Bottiglieri L, Iorfida M, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2010 Dec;124(3):689-99. doi: 10.1007/s10549-010-1027-4. Epub 2010 Jul 13. Breast Cancer Res Treat. 2010. PMID: 20625816
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.
Montagna E, Cancello G, Bagnardi V, Pastrello D, Dellapasqua S, Perri G, Viale G, Veronesi P, Luini A, Intra M, Calleri A, Rampinelli C, Goldhirsch A, Bertolini F, Colleoni M. Montagna E, et al. Among authors: bagnardi v. Clin Breast Cancer. 2012 Jun;12(3):207-14. doi: 10.1016/j.clbc.2012.03.008. Epub 2012 Apr 20. Clin Breast Cancer. 2012. PMID: 22520733 Clinical Trial.
Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases.
Botteri E, Munzone E, Intra M, Bagnardi V, Rotmensz N, Bazolli B, Montanari B, Aurilio G, Sciandivasci A, Esposito A, Pagani G, Adamoli L, Viale G, Nolè F, Goldhirsch A. Botteri E, et al. Among authors: bagnardi v. Breast Cancer Res Treat. 2013 Feb;138(1):303-10. doi: 10.1007/s10549-013-2449-6. Epub 2013 Feb 15. Breast Cancer Res Treat. 2013. PMID: 23412771
330 results